VANGUARD GROUP INC

Holdings History for Coherus Oncology, Inc. - Common Stock, par value $0.0001 per share (CHRS)

Symbol
CHRS on Nasdaq
Investment type
Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned
10,028,893 shares
Security Ownership %
8.3%
Shares, Excluding Options vs Price
Value, Excluding Options

The Vanguard Group ownership in Coherus Oncology, Inc. Common Stock, par value $0.0001 per share (CHRS)

30 Jan 2026 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 10,028,893 shares of Coherus Oncology, Inc. Common Stock, par value $0.0001 per share (CHRS). This represents 8.3% ownership of the company. This is the first filing by VANGUARD GROUP INC disclosing ownership of Coherus Oncology, Inc. Common Stock, par value $0.0001 per share (CHRS).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.